David A. Siegel Mannkind Corp Transaction History

Two Sigma Advisers, LP

$42.5 Billion
Q1 2024

A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Mannkind Corp stock. As of the latest transaction made, Two Sigma Advisers, LP holds 1,327,627 shares of MNKD stock, worth $6.93 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,327,627

Previous 1,083,127 22.57%

Holding current value

$6.93 Million

Previous $3.94 Million 52.56%

% of portfolio

0.01%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$3.25 - $5.27 $794,625 - $1.29 Million	244,500 Added 22.57%	1,327,627 $6.01 Million
Q4 2023 Feb 14, 2024	SELL	$3.34 - $4.29 $1.79 Million - $2.3 Million	-536,500 Reduced 33.12%	1,083,127 $3.94 Million
Q3 2023 Nov 14, 2023	BUY	$3.91 - $5.45 $323,357 - $450,715	82,700 Added 5.38%	1,619,627 $6.69 Million
Q2 2023 Aug 14, 2023	SELL	$3.72 - $4.79 $1.9 Million - $2.45 Million	-511,500 Reduced 24.97%	1,536,927 $6.26 Million
Q1 2023 May 15, 2023	BUY	$3.95 - $5.63 $7.18 Million - $10.2 Million	1,817,400 Added 786.66%	2,048,427 $8.4 Million

Q4 2022 Feb 14, 2023	BUY	$3.02 - $5.37 $697,701 - $1.24 Million	231,027 New	231,027 $1.22 Million
Q2 2022 Aug 15, 2022	BUY	$2.67 - $4.77 $35,057 - $62,630	13,130 New	13,130 $50,000
Q1 2022 May 16, 2022	SELL	$2.62 - $4.45 $50,828 - $86,330	-19,400 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$4.05 - $5.37 $1.18 Million - $1.57 Million	-291,647 Reduced 93.76%	19,400 $85,000
Q3 2021 Nov 15, 2021	SELL	$3.89 - $5.48 $4.28 Million - $6.03 Million	-1,101,001 Reduced 77.97%	311,047 $1.35 Million
Q2 2021 Aug 16, 2021	SELL	$3.61 - $5.45 $5.34 Million - $8.06 Million	-1,478,400 Reduced 51.15%	1,412,048 $7.7 Million
Q1 2021 May 17, 2021	BUY	$3.14 - $6.14 $4.5 Million - $8.81 Million	1,434,200 Added 98.49%	2,890,448 $11.3 Million
Q4 2020 Feb 16, 2021	BUY	$1.79 - $4.04 $1.09 Million - $2.47 Million	611,300 Added 72.35%	1,456,248 $4.56 Million
Q3 2020 Nov 16, 2020	BUY	$1.56 - $2.08 $1.13 Million - $1.5 Million	721,778 Added 586.0%	844,948 $1.59 Million
Q2 2020 Aug 14, 2020	BUY	$0.94 - $2.21 $115,779 - $272,205	123,170 New	123,170 $216,000
Q3 2019 Nov 14, 2019	SELL	$1.04 - $1.44 $240,344 - $332,784	-231,100 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$1.09 - $1.88 $15,696 - $27,072	-14,400 Reduced 5.87%	231,100 $266,000
Q1 2019 May 15, 2019	BUY	$1.14 - $2.25 $1,937 - $3,825	1,700 Added 0.7%	245,500 $484,000
Q4 2018 Feb 14, 2019	SELL	$1.02 - $2.05 $26,214 - $52,684	-25,700 Reduced 9.54%	243,800 $258,000
Q3 2018 Nov 14, 2018	SELL	$1.01 - $2.19 $32,623 - $70,737	-32,300 Reduced 10.7%	269,500 $493,000
Q2 2018 Aug 14, 2018	BUY	$1.59 - $2.38 $33,390 - $49,980	21,000 Added 7.48%	301,800 $573,000
Q1 2018 May 15, 2018	BUY	$2.28 - $3.8 $251,711 - $419,520	110,400 Added 64.79%	280,800 $640,000
Q4 2017 Feb 14, 2018	BUY	$2.28 - $6.71 $355,679 - $1.05 Million	156,000 Added 1083.33%	170,400 $395,000
Q3 2017 Nov 14, 2017	BUY	$1.15 - $2.29 $16,560 - $32,976	14,400	14,400 $31,000

Others Institutions Holding MNKD

# of Institutions

209

Shares Held

130M

Call Options Held

1.81M

Put Options Held

808K

View Full List

About MANNKIND CORP

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $1.34B
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

More about MNKD

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account